Nymox Pharma (NYMX) Shares See Late-Day Selling
- Wall Street hits record high for third day in a row
- 21st Century Fox (FOXA) offers to acquire Sky for GBP10.75/share
- Coca Cola (KO) Announces James Quincey to Succeed Muhtar Kent as CEO; Kent to Continue as Chairman
- Exclusive: Japan's TDK in talks to buy iPhone supplier InvenSense - sources
- Broadcom Ltd. (AVGO) Tops Q4 EPS by 11c
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Nymox Pharma (NASDAQ: NYMX) is seeing a sharper drop to session lows. The stock is now down over 23 percent on the session.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Japan's TDK in Talks to Buy InvenSense (INVN) - Reuters
- Sunshine Heart (SSH) Adds to Thursday's Big Gains
- Macau Casinos Pare Losses as Analysts Reject ATM Cap Report - Bloomberg (WYNN) (MGM) (LVS) (MPEL)
Create E-mail Alert Related CategoriesMomentum Movers, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!